Problem-Solving Skills Training for Parents of Children Undergoing Hematopoietic Stem Cell Transplantation: A Feasibility Study

October 21, 2025 updated by: Bemis, Heather, Children's Hospital Los Angeles

The goal of this clinical trial is to test the feasibility and acceptability of the Bright IDEAS problem-solving skills training (PSST) intervention for parents of children undergoing hematopoietic stem cell transplantation (HSCT). The main question aims to answer:

  • Determine the feasibility and acceptability of a multimodal PSST intervention for English and Spanish-speaking parents of children and adolescents undergoing autologous and allogeneic HSCT using a randomized controlled trial design and mixed methods approach to evaluation
  • To evaluate the effectiveness of a PSST intervention on PSS acquisition and psychological distress compared to a control group of parents receiving non-directive psychosocial care (n=25).
  • To explore the effect of the parent PSST on child quality of life (QoL) and self-reported symptoms, mediated by parent psychological distress

If there is a comparison group: Researchers will compare PSST intervention usual or standard psychosocial care.

Participants will complete 6-8 sessions of intervention. All participants will complete surveys.

Study Overview

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90027
        • Children's Hospital Los Angeles

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Children

Inclusion Criteria:

  • Male and females of any race or ethnicity, ages 0 to 21 years
  • Allogeneic or autologous HSCT planned with reduced intensity or myeloablative conditioning

Exclusion Criteria:

  • Concurrent enrollment on a research study testing psychoeducational interventions for parents and/or patients

Parent

Inclusion Criteria:

  • One parent or primary caregiver per child
  • Able to speak, read, and write English or Spanish, and give informed consent

Exclusion Criteria:

  • Child or adolescent refusal to participate
  • Parent age less than 18 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Standard of care.
Experimental: Problem-Solving Skills Training
Bright ideas problem solving skills intervention.
Intervention materials include instructor and user manuals, a brochure, and worksheets to be completed by the parent caregiver, initially with the help of the interventionist, during four weekly face-to-face (F2F) sessions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Bright IDEAS for parents
Time Frame: Baseline to 180 days
Percent eligible participants who consent/assent to participate and Number of sessions completed by enrolled participants.
Baseline to 180 days
Bright IDEAS Acceptability
Time Frame: Between day 60 and day 90
Qualitative Interviews will assess participant satisfaction with the intervention format, timing, and content; impact; barriers; and suggestions for refinement.
Between day 60 and day 90

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parent Problem Solving Skills
Time Frame: Baseline to 180 days
Social Problem-Solving Skills Inventory-Revised Short Form
Baseline to 180 days
Parent Negative Affectivity
Time Frame: Baseline to 180 days
Profile of Mood States Short Form
Baseline to 180 days
Parent Anxiety
Time Frame: Baseline to 180 days
Beck Anxiety Inventory
Baseline to 180 days
Parent Depression
Time Frame: Baseline to 180 days
Beck Depression Inventory
Baseline to 180 days
Parent Post-traumatic Stress
Time Frame: Baseline to 180 days
Impact of events scale revised
Baseline to 180 days
Children Symptom Burden
Time Frame: Baseline to 180 days
Memorial Symptoms Assessment Scale (Child Version & Parent Proxy for children ages 2-6 years)
Baseline to 180 days
Children Health-Related Quality of Life
Time Frame: Baseline to 180 days
PedsQL Cancer Module (Child Version & Parent Proxy for children ages 2-4 years)
Baseline to 180 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather Bemis, Children's Hospital Los Angeles

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2020

Primary Completion (Actual)

May 23, 2023

Study Completion (Actual)

May 23, 2023

Study Registration Dates

First Submitted

October 20, 2025

First Submitted That Met QC Criteria

October 20, 2025

First Posted (Estimated)

October 22, 2025

Study Record Updates

Last Update Posted (Actual)

October 23, 2025

Last Update Submitted That Met QC Criteria

October 21, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stem Cell Transplantation

Clinical Trials on Bright Ideas Problem-Solving Skills Training

3
Subscribe